The ligand N-[2-amino-3-(p-isothiocyanatophenyl)propyl]-(±)-trans-1,2-diaminocyclohexane-N,Nâ²,Nâ³-pentaacetic acid has been synthesized and linked to IgG and to monoclonal antibody B72.3, and labelled with 206Bi and 212Bi to demonstrate the in vivo stability of the label and its utility for 212Bi-radioimmunotherapy.
配体 N-[2-
氨基-3-(对异
硫氰酸苯基)丙基]-(±)-反式-
1,2-二氨基环己烷-N,N-2,N-3-五
乙酸已合成并连接到IgG 和单克隆
抗体 B72.3,并用 206Bi 和 212Bi 标记,以证明标记的体内稳定性及其在 212Bi 放射免疫治疗中的实用性。